Answer
Its UK licence covers selected NTRK fusion-positive solid tumours in adults and young people aged 12 years or over, and ROS1-positive advanced non-small-cell lung cancer in adults.
Sources for this answer
- Rozlytrek 100 mg & 200 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.